UPDATE : Tuesday, March 19, 2019
NK Max submits plans for P1 clinical trial for immunotherapy in US
NK Max, a local pharmaceutical company, said Tuesday that it has applied fo...
by Lee Han-soo  |  2019-01-16 11:36
Intra-articular injection Conjuran recognized as new medical tech
The government recognized Pharma Research Products’ intra-articular injecti...
by Lee Hye-seon  |  2019-01-15 14:07
Baxter’s dialyzer suspended due to bad-mouthing rival products
The government ordered Baxter to suspend the sale of Theranova, a blood fil...
by Lee Hye-seon  |  2019-01-15 11:42
Takeda Korea names Moon Hee-seok as new CEO
Takeda Pharmaceuticals Korea said Monday it appointed Moon Hee-seok, CEO of...
by Lee Han-soo  |  2019-01-15 11:40
CancerRop secures CAR-T source technology
CancerRop said Monday that its subsidiary MJ Cellbio has licensed in a CAR-...
by Lee Han-soo  |  2019-01-14 15:28
5 pharmaceuticals win nod for sustained-release neuropathic pain reliever
Five local drugmakers have obtained approval for medicines that changed the...
by Lee Hye-seon  |  2019-01-14 14:56
14 drugmakers to release generic copies of Stillen 2X in early February
Fourteen pharmaceutical companies are likely to roll out generic drugs that...
by Lee Hye-seon  |  2019-01-14 11:34
Dongkoo to test stem cell therapy for diabetic foot ulcers
Dongkoo Bio & Pharma said it would conduct a clinical trial to expand the t...
by Lee Hye-seon  |  2019-01-11 15:53
Pharmaceuticals present future strategy at JP Morgan Healthcare Conference
Korean pharmaceutical and biotechnology companies emphasized their competit...
by Lee Han-soo  |  2019-01-10 18:20
Six Tamiflu takers suffered abnormalities in 5 years
Six patients who received influenza treatment Tamiflu had neuropsychiatric ...
by Song Soo-youn  |  2019-01-10 14:19
Tego Science releases research results for diabetic foot ulcer treatment
Tego science said Thursday that it has confirmed the superior efficacy resu...
by Lee Han-soo  |  2019-01-10 12:48
MSD Korea recalls HIV drug Stocrin with particular code
MSD Korea said it would recall HIV treatment Stocrin (ingredient: efavirenz...
by Lee Hye-seon  |  2019-01-10 11:46
Pfizer to stop renewing risk-sharing accord for lung cancer drug
Pfizer said it would not renew its risk-sharing agreement (RSA) for Xalkori...
by Lee Han-soo  |  2019-01-10 10:40
Hugel wins patent for patch-type BTX product
Hugel said Wednesday that it has registered a patent for the microstructure...
by Lee Han-soo  |  2019-01-09 16:31
Hanmi to start P1 trial about diabetes combination treatment
Hanmi Pharmaceutical has received approval from the Ministry of Food and Dr...
by Lee Han-soo  |  2019-01-09 14:51
Pharma Research Bio to start P1 clinical trials about BTX
Pharma Research Bio said Monday that it has received approval from the Mini...
by Lee Han-soo  |  2019-01-09 14:51
Regulator keeps Kyung Nam Pharm listed with 1-year grace period
The Korean stock market operator decided to keep Kyung Nam Pharm listed on ...
by Lee Hye-seon  |  2019-01-09 14:49
Anti-Alzheimer drink Souvenaid mired in illegal ad controversy -- again
Handok has illegally promoted Souvenaid, a new drink for mild cognitive imp...
by Lee Min-ju  |  2019-01-08 16:10
Handok and Genexine become largest stakeholder of Rezolute
Korean pharmaceuticals Handok and Genexine said they have jointly become th...
by Lee Hye-seon  |  2019-01-08 14:53
GC, CANbridge ink licensing agreement for Hunter Syndrome drug
GC said Tuesday that it has signed an exclusive licensing agreement in the ...
by Lee Han-soo  |  2019-01-08 12:15
Back to Top